This post-market clinical study is being done to evaluate the use of the NovaLign™ Intramedullary Fixation System in the treatment of humeral fractures.
This is an observational, prospective, nonrandomized open label, post-market clinical study, designed to evaluate the use a flexible intramedullary fixation device used in the treatment of fractures of the humerus. This is a multicentre trial.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
20
Intramedullary fixation of broken humerus
Denver Health Medical Center
Denver, Colorado, United States
RECRUITINGUniversity of Missouri - Columbia
Columbia, Missouri, United States
RECRUITINGRadiographic union and safety
Time frame: 12 months
Function, pain, and quality of life assessments at regular intervals
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.